Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae

PHASE3CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Digestive Fistulae
Interventions
DRUG

Lanreotide microparticles

DRUG

Placebo

Trial Locations (19)

13915

Hôpital Nord, Marseille

25031

CHU J. Minjoz, Besançon

29609

Hôpital de la Cavale Blanche, Brest

35033

Hôpital Pontchaillou, Rennes

37044

Hôpital Trousseau, Tours

38043

Hôpital A. Michallon, Grenoble

54500

Hôpital de Brabois, Vandœuvre-lès-Nancy

67098

Hôpital de Hautepierre, Strasbourg

69003

Hôpital Edouard Herriot, Lyon

69288

Hotel Dieu, Lyon

75010

Hôpital Lariboisière, Paris

75013

Groupe Hospitalier Pitié-Salpêtrière, Paris

80054

Hôpital Nord, Amiens

92700

Hôpital Louis Mourier, Colombes

93009

Hôpital Avicenne, Bobigny

94000

Hôpital Henri Mondor, Créteil

94275

CHU de Bicêtre, Le Kremlin-Bicêtre

113811

Institute of Surgery n.a. A.V. Vishnevsky, Moscow

119992

National Research Centre of Surgery, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY